Evidence of increased Fentanyl use during the COVID-19 pandemic among opioid agonist treatment patients in Ontario, Canada

BACKGROUND: Amid the opioid crisis, the health care system is restructuring to prevent and treat COVID-19. Individuals in opioid agonist treatment (OAT) are uniquely challenged because of disruption to treatment, medication diversion, and isolation during the pandemic. METHODS: Between January and S...

Descripción completa

Detalles Bibliográficos
Autores principales: Morin, Kristen A., Acharya, Shreedhar, Eibl, Joseph K., Marsh, David C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier B.V. 2021
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834895/
https://www.ncbi.nlm.nih.gov/pubmed/33385974
http://dx.doi.org/10.1016/j.drugpo.2020.103088

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834895/
https://www.ncbi.nlm.nih.gov/pubmed/33385974
http://dx.doi.org/10.1016/j.drugpo.2020.103088

Ejemplares similares